Agilent Technologies Inc (NYSE:A) insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 4th. The shares were sold at an average price of $56.50, for a total value of $282,500.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Patrick Kaltenbach also recently made the following trade(s):
- On Monday, April 24th, Patrick Kaltenbach sold 2,000 shares of Agilent Technologies stock. The shares were sold at an average price of $54.50, for a total value of $109,000.00.
- On Monday, April 10th, Patrick Kaltenbach sold 2,000 shares of Agilent Technologies stock. The shares were sold at an average price of $52.90, for a total value of $105,800.00.
- On Thursday, February 16th, Patrick Kaltenbach sold 3,771 shares of Agilent Technologies stock. The shares were sold at an average price of $51.68, for a total value of $194,885.28.
Shares of Agilent Technologies Inc (NYSE:A) traded up 0.50% during trading on Friday, hitting $56.13. The company had a trading volume of 1,654,441 shares. The firm has a 50 day moving average of $54.57 and a 200 day moving average of $49.85. Agilent Technologies Inc has a 12-month low of $41.98 and a 12-month high of $58.38. The stock has a market cap of $18.09 billion, a PE ratio of 36.00 and a beta of 1.19.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, February 14th. The medical research company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.49 by $0.04. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Agilent Technologies had a net margin of 10.99% and a return on equity of 15.49%. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS. On average, analysts forecast that Agilent Technologies Inc will post $2.16 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd will be given a dividend of $0.132 per share. This represents a $0.53 annualized dividend and a dividend yield of 0.95%. The ex-dividend date is Thursday, June 29th. Agilent Technologies’s payout ratio is 37.59%.
Several hedge funds have recently modified their holdings of the stock. BlackRock Inc. boosted its stake in shares of Agilent Technologies by 1,946.9% in the first quarter. BlackRock Inc. now owns 23,119,219 shares of the medical research company’s stock valued at $1,222,310,000 after buying an additional 21,989,739 shares during the last quarter. Norges Bank acquired a new stake in shares of Agilent Technologies during the fourth quarter valued at approximately $118,636,000. FMR LLC boosted its stake in Agilent Technologies by 11.8% in the fourth quarter. FMR LLC now owns 20,784,414 shares of the medical research company’s stock worth $946,938,000 after buying an additional 2,200,865 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Agilent Technologies by 31.4% in the first quarter. JPMorgan Chase & Co. now owns 8,366,511 shares of the medical research company’s stock worth $442,338,000 after buying an additional 1,999,376 shares in the last quarter. Finally, MARSHALL WACE ASIA Ltd purchased a new stake in Agilent Technologies during the first quarter worth approximately $58,065,000.
A has been the topic of several research analyst reports. Janney Montgomery Scott lifted their price target on Agilent Technologies from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, February 13th. Zacks Investment Research upgraded Agilent Technologies from a “sell” rating to a “hold” rating in a research report on Friday, February 17th. Morgan Stanley upgraded Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $62.00 price target on the stock in a research report on Wednesday, March 15th. Jefferies Group LLC reiterated a “buy” rating and set a $59.00 price target on shares of Agilent Technologies in a research report on Friday, March 17th. Finally, Deutsche Bank AG reiterated a “buy” rating and set a $58.00 price target (up from $56.00) on shares of Agilent Technologies in a research report on Sunday, April 2nd. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Agilent Technologies has a consensus rating of “Buy” and a consensus target price of $55.46.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.